Angiogenesis in ischemic stroke and angiogenic effects of chinese herbal medicine

Journal of Clinical Medicine

Volumn 5, Issue 6, 2016, Pages

  Seto, Sai Wang ^a   Chang, Dennis ^a   Jenkins, Anita ^a   Bensoussan, Alan ^a   Kiat, Hosen ^b,c,d  

^a WESTERN SYDNEY UNIVERSITY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

^d MACQUARIE UNIVERSITY   (Australia)

Author keywords

Angiogenesis; Cerebral ischemia; Chinese Herbal Medicine; Stroke

Indexed keywords

ANGIOGENIN; ANGIOPOIETIN; ANGIOPOIETIN 1; BUYANG HUANWU DECOCTION; CHINESE DRUG; DANGGUI SHAOYAO SAN; FIBROBLAST GROWTH FACTOR 2; HERBACEOUS AGENT; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; KI 67 ANTIGEN; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; TONGXINLUO; TRANSFORMING GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN E;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; BLOOD BRAIN BARRIER; BONE MARROW STROMA CELL; BRAIN ISCHEMIA; CHINESE MEDICINE; ECHOGRAPHY; EXTRACELLULAR MATRIX; HERBAL MEDICINE; HUMAN; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 85067220103     PISSN: None     EISSN: 20770383     Source Type: Journal    
DOI: 10.3390/jcm5060056     Document Type: Review

References (128)

1. Romero, J.R. Prevention of ischemic stroke: Overview of traditional risk factors. Curr. Drug Targets 2007, 8, 794–801. [CrossRef] [PubMed]
2. Mehta, S.L.; Manhas, N.; Raghubir, R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res. Rev. 2007, 54, 34–66. [CrossRef] [PubMed]
3. Dyken, M.L. What lessons have we learned in the past 40 years? Stroke 2010, 41, 1073–1075. [CrossRef] [PubMed]
4. Roth, J.M. Recombinant tissue plasminogen activator for the treatment of acute ischemic stroke. Proceedings (Bayl. Univ. Med. Cent.) 2011, 24, 257–259.
5. IST-3 Collaborative Group; Sandercock, P.; Wardlaw, J.M.; Lindley, R.I.; Dennis, M.; Cohen, G.; Murray, G.; Innes, K.; Venables, G.; Czlonkowska, A.; et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): A randomised controlled trial. Lancet 2012, 379, 2352–2363.
6. Krupinski, J.; Kaluza, J.; Kumar, P.; Kumar, S.; Wang, J.M. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 1994, 25, 1794–1798. [CrossRef] [PubMed]
7. Arenillas, J.F.; Sobrino, T.; Castillo, J.; Davalos, A. The role of angiogenesis in damage and recovery from ischemic stroke. Curr. Treat. Options Cardiovasc. Med. 2007, 9, 205–212. [CrossRef] [PubMed]
8. Ferrara, N.; Kerbel, R.S. Angiogenesis as a therapeutic target. Nature 2005, 438, 967–974. [CrossRef] [PubMed]
9. Chen, R.L.; Balami, J.S.; Esiri, M.M.; Chen, L.K.; Buchan, A.M. Ischemic stroke in the elderly: An overview of evidence. Nat. Rev. Neurol. 2010, 6, 256–265. [CrossRef] [PubMed]
10. Wei, L.; Keogh, C.L.; Whitaker, V.R.; Theus, M.H.; Yu, S.P. Angiogenesis and stem cell transplantation as potential treatments of cerebral ischemic stroke. Pathophysiology 2005, 12, 47–62. [CrossRef] [PubMed]
11. Arab, L.; Liu, W.; Elashoff, D. Green and black tea consumption and risk of stroke: A meta-analysis. Stroke 2009, 40, 1786–1792. [CrossRef] [PubMed]
12. Chen, Y.C.; Wu, J.S.; Yang, S.T.; Huang, C.Y.; Chang, C.; Sun, G.Y.; Lin, T.N. Stroke, angiogenesis and phytochemicals. Front. Biosci. (Sch. Ed.) 2012, 4, 599–610.
13. Del Zoppo, G.J.; Mabuchi, T. Cerebral microvessel responses to focal ischemia. J. Cereb. Blood Flow Metab. 2003, 23, 879–894. [CrossRef] [PubMed]
14. Krupinski, J.; Kaluza, J.; Kumar, P.; Kumar, S.; Wang, J.M. Some remarks on the growth-rate and angiogenesis of microvessels in ischemic stroke. Morphometric and immunocytochemical studies. Patol. Pol. 1993, 44, 203–209. [PubMed]
15. Hayashi, T.; Noshita, N.; Sugawara, T.; Chan, P.H. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J. Cereb. Blood Flow Metab. 2003, 23, 166–180. [CrossRef] [PubMed]
16. Marti, H.J.; Bernaudin, M.; Bellail, A.; Schoch, H.; Euler, M.; Petit, E.; Risau, W. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am. J. Pathol. 2000, 156, 965–976. [CrossRef]
17. Iadecola, C. The pathobiology of vascular dementia. Neuron 2013, 80, 844–866. [CrossRef] [PubMed]
18. Fan, Y.; Yang, G.Y. Therapeutic angiogenesis for brain ischemia: A brief review. J. Neuroimmune Pharmacol. 2007, 2, 284–289. [CrossRef] [PubMed]
19. Beck, H.; Plate, K.H. Angiogenesis after cerebral ischemia. Acta Neuropathol. 2009, 117, 481–496. [CrossRef] [PubMed]
20. Kawabe, T.; Wen, T.C.; Matsuda, S.; Ishihara, K.; Otsuda, H.; Sakanaka, M. Platelet-derived growth factor prevents ischemia-induced neuronal injuries in vivo. Neurosci. Res. 1997, 29, 335–343. [CrossRef]
21. Lin, T.N.; Kim, G.M.; Chen, J.J.; Cheung, W.M.; He, Y.Y.; Hsu, C.Y. Differential regulation of thrombospondin-1 and thrombospondin-2 after focal cerebral ischemia/reperfusion. Stroke 2003, 34, 177–186. [CrossRef] [PubMed]
22. Lin, T.N.; Te, J.; Lee, M.; Sun, G.Y.; Hsu, C.Y. Induction of basic fibroblast growth factor (bFGF) expression following focal cerebral ischemia. Mol. Brain Res. 1997, 49, 255–265. [CrossRef]
23. Talwar, T.; Srivastava, M.V. Role of vascular endothelial growth factor and other growth factors in post-stroke recovery. Ann. Indian Acad Neurol. 2014, 17, 1–6. [PubMed]
24. Zhao, B.Q.; Wang, S.; Kim, H.Y.; Storrie, H.; Rosen, B.R.; Mooney, D.J.; Wang, X.; Lo, E.H. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat. Med. 2006, 12, 441–445. [CrossRef] [PubMed]
25. Carmeliet, P.; Collen, D. Molecular basis of angiogenesis. Role of VEGF and VE-Cadherin. Ann. N. Y. Acad Sci. 2000, 902, 249–264. [CrossRef] [PubMed]
26. Feng, Y.; Vom Hagen, F.; Wang, Y.; Beck, S.; Schreiter, K.; Pfister, F.; Hoffmann, S.; Wagner, P.; Seeliger, M.; Molema, G.; et al. The absence of angiopoietin-2 leads to abnormal vascular maturation and persistent proliferative retinopathy. Thromb. Haemost. 2009, 102, 120–130. [CrossRef] [PubMed]
27. Lutsenko, S.V.; Kiselev, S.M.; Severin, S.E. Molecular mechanisms of tumor angiogenesis. Biochemistry (Moscow) 2003, 68, 286–300. [CrossRef] [PubMed]
28. Chen, A.; Oakley, A.E.; Monteiro, M.; Tuomela, K.; Allan, L.M.; Mukaetova-Ladinska, E.B.; O’Brien, J.T.; Kalaria, R.N. Multiplex analyte assays to characterize different dementias: Brain inflammatory cytokines in poststroke and other dementias. Neurobiol. Aging 2016, 38, 56–67. [CrossRef] [PubMed]
29. Gertz, K.; Kronenberg, G.; Kalin, R.E.; Baldinger, T.; Werner, C.; Balkaya, M.; Eom, G.D.; Hellmann-Regen, J.; Krober, J.; Miller, K.R.; et al. Essential role of interleukin-6 in post-stroke angiogenesis. Brain 2012, 135, 1964–1980. [CrossRef] [PubMed]
30. Goto, F.; Goto, K.; Weindel, K.; Folkman, J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab. Investig. 1993, 69, 508–517. [PubMed]
31. Stavri, G.T.; Zachary, I.C.; Baskerville, P.A.; Martin, J.F.; Erusalimsky, J.D. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation 1995, 92, 11–14. [CrossRef] [PubMed]
32. Ferrara, N. Vascular endothelial growth factor: Basic science and clinical progress. Endocr. Rev. 2004, 25, 581–611. [CrossRef] [PubMed]
33. Asahi, M.; Wang, X.; Mori, T.; Sumii, T.; Jung, J.C.; Moskowitz, M.A.; Fini, M.E.; Lo, E.H. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 2001, 21, 7724–7732. [PubMed]
34. Montaner, J.; Molina, C.A.; Monasterio, J.; Abilleira, S.; Arenillas, J.F.; Ribo, M.; Quintana, M.; Alvarez-Sabin, J. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 2003, 107, 598–603. [CrossRef] [PubMed]
35. Yin, K.J.; Hamblin, M.; Chen, Y.E. Angiogenesis-regulating microRNAs and ischemic stroke. Curr. Vasc. Pharmacol. 2015, 13, 352–365. [CrossRef] [PubMed]
36. Tammela, T.; Enholm, B.; Alitalo, K.; Paavonen, K. The biology of vascular endothelial growth factors. Cardiovasc. Res. 2005, 65, 550–563. [CrossRef] [PubMed]
37. Robinson, C.J.; Stringer, S.E. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci. 2001, 114, 853–865. [PubMed]
38. Takahashi, S. Vascular endothelial growth factor (VEGF), vegf receptors and their inhibitors for antiangiogenic tumor therapy. Biol. Pharm. Bull. 2011, 34, 1785–1788. [CrossRef] [PubMed]
39. Gerber, H.P.; Condorelli, F.; Park, J.; Ferrara, N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J. Biol. Chem. 1997, 272, 23659–23667. [CrossRef] [PubMed]
40. Albasanz-Puig, A.; Murray, J.; Namekata, M.; Wijelath, E.S. Opposing roles of STAT-1 and STAT-3 in regulating vascular endothelial growth factor expression in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 2012, 428, 179–184. [CrossRef] [PubMed]
41. Facemire, C.S.; Nixon, A.B.; Griffiths, R.; Hurwitz, H.; Coffman, T.M. Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression. Hypertension 2009, 54, 652–658. [CrossRef] [PubMed]
42. Polverini, P.J. Angiogenesis in health and disease: Insights into basic mechanisms and therapeutic opportunities. J. Dent. Educ. 2002, 66, 962–975. [PubMed]
43. Sun, Y.; Jin, K.; Xie, L.; Childs, J.; Mao, X.O.; Logvinova, A.; Greenberg, D.A. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Investig. 2003, 111, 1843–1851. [CrossRef] [PubMed]
44. Wang, P.; Xie, Z.H.; Guo, Y.J.; Zhao, C.P.; Jiang, H.; Song, Y.; Zhu, Z.Y.; Lai, C.; Xu, S.L.; Bi, J.Z. Vegf-induced angiogenesis ameliorates the memory impairment in app transgenic mouse model of alzheimer’s disease. Biochem. Biophys. Res. Commun. 2011, 411, 620–626. [CrossRef] [PubMed]
45. Wang, Y.; Hu, Y.; Sun, C.; Zhang, X.; He, W. Mechanism of arsenic trioxide inhibiting angiogenesis in multiple myeloma. J. Huazhong Univ. Sci. Technol. (Med. Sci.) 2006, 26, 43–46.
46. Greenberg, D.A.; Jin, K. From angiogenesis to neuropathology. Nature 2005, 438, 954–959. [CrossRef] [PubMed]
47. Zhang, Z.G.; Zhang, L.; Jiang, Q.; Zhang, R.; Davies, K.; Powers, C.; Bruggen, N.; Chopp, M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Investig. 2000, 106, 829–838. [CrossRef] [PubMed]
48. Manoonkitiwongsa, P.S.; Jackson-Friedman, C.; McMillan, P.J.; Schultz, R.L.; Lyden, P.D. Angiogenesis after stroke is correlated with increased numbers of macrophages: The clean-up hypothesis. J. Cereb. Blood Flow Metab. 2001, 21, 1223–1231. [CrossRef] [PubMed]
49. Zhang, Z.G.; Chopp, M. Promoting brain remodeling to aid in stroke recovery. Trends Mol. Med. 2015, 21, 543–548. [CrossRef] [PubMed]
50. Zeng, L.; He, X.; Wang, Y.; Tang, Y.; Zheng, C.; Cai, H.; Liu, J.; Wang, Y.; Fu, Y.; Yang, G.Y. MicroRNA-210 overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain. Gene Ther. 2014, 21, 37–43. [CrossRef] [PubMed]
51. Liu, F.J.; Kaur, P.; Karolina, D.S.; Sepramaniam, S.; Armugam, A.; Wong, P.T.; Jeyaseelan, K. MiR-335 regulates Hif-1α to reduce cell death in both mouse cell line and rat ischemic models. PLoS ONE 2015, 10, e0128432. [CrossRef] [PubMed]
52. Qu, Y.; Wu, J.; Chen, D.; Zhao, F.; Liu, J.; Yang, C.; Wei, D.; Ferriero, D.M.; Mu, D. MiR-139-5p inhibits HGTD-P and regulates neuronal apoptosis induced by hypoxia-ischemia in neonatal rats. Neurobiol. Dis. 2014, 63, 184–193. [CrossRef] [PubMed]
53. Sun, J.; Tao, S.; Liu, L.; Guo, D.; Xia, Z.; Huang, M. MiR-140-5p regulates angiogenesis following ischemic stroke by targeting vegfa. Mol. Med. Rep. 2016, 13, 4499–4505. [CrossRef] [PubMed]
54. He, Q.W.; Li, Q.; Jin, H.J.; Zhi, F.; Suraj, B.; Zhu, Y.Y.; Xia, Y.P.; Mao, L.; Chen, X.L.; Hu, B. MiR-150 regulates poststroke cerebral angiogenesis via vascular endothelial growth factor in rats. CNS Neurosci. Ther. 2016, 22, 507–517. [CrossRef] [PubMed]
55. Lin, T.N.; Nian, G.M.; Chen, S.F.; Cheung, W.M.; Chang, C.; Lin, W.C.; Hsu, C.Y. Induction of Tie-1 and Tie-2 receptor protein expression after cerebral ischemia-reperfusion. J. Cereb. Blood Flow Metab. 2001, 21, 690–701. [CrossRef] [PubMed]
56. Armstrong, L.C.; Bornstein, P. Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Matrix Biol. 2003, 22, 63–71. [CrossRef]
57. Ward, N.L.; Dumont, D.J. The angiopoietins and Tie2/Tek: Adding to the complexity of cardiovascular development. Semin. Cell Dev. Biol. 2002, 13, 19–27. [CrossRef] [PubMed]
58. Johansson, B.B.; Grabowski, M. Functional recovery after brain infarction: Plasticity and neural transplantation. Brain Pathol. 1994, 4, 85–95. [CrossRef] [PubMed]
59. Bahramsoltani, M.; Plendl, J.; Janczyk, P.; Custodis, P.; Kaessmeyer, S. Quantitation of angiogenesis and antiangiogenesis in vivo, ex vivo and in vitro—An overview. ALTEX 2009, 26, 95–107. [PubMed]
60. Zhang, Y.; Hu, G.; Lin, H.C.; Hong, S.J.; Deng, Y.H.; Tang, J.Y.; Seto, S.W.; Kwan, Y.W.; Waye, M.M.; Wang, Y.T.; et al. Radix astragali extract promotes angiogenesis involving vascular endothelial growth factor receptor-related phosphatidylinositol 3-kinase/Akt-dependent pathway in human endothelial cells. Phytother. Res. 2009, 23, 1205–1213. [CrossRef] [PubMed]
61. Cross, L.M.; Cook, M.A.; Lin, S.; Chen, J.N.; Rubinstein, A.L. Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 911–912. [CrossRef] [PubMed]
62. Baldessari, D.; Mione, M. How to create the vascular tree? (Latest) help from the zebrafish. Pharmacol. Ther. 2008, 118, 206–230. [CrossRef] [PubMed]
63. Seto, S.W.; Kiat, H.; Lee, S.M.; Bensoussan, A.; Sun, Y.T.; Hoi, M.P.; Chang, D. Zebrafish models of cardiovascular diseases and their applications in herbal medicine research. Eur. J. Pharmacol. 2015, 768, 77–86. [CrossRef] [PubMed]
64. Hong, S.J.; Wan, J.B.; Zhang, Y.; Hu, G.; Lin, H.C.; Seto, S.W.; Kwan, Y.W.; Lin, Z.X.; Wang, Y.T.; Lee, S.M. Angiogenic effect of saponin extract from Panax notoginseng on huvecs in vitro and zebrafish in vivo. Phytother. Res. 2009, 23, 677–686. [CrossRef] [PubMed]
65. Lucidarme, O.; Kono, Y.; Corbeil, J.; Choi, S.H.; Golmard, J.L.; Varner, J.; Mattrey, R.F. Angiogenesis: Noninvasive quantitative assessment with contrast-enhanced functional us in murine model. Radiology 2006, 239, 730–739. [CrossRef] [PubMed]
66. Willmann, J.K.; Paulmurugan, R.; Chen, K.; Gheysens, O.; Rodriguez-Porcel, M.; Lutz, A.M.; Chen, I.Y.; Chen, X.; Gambhir, S.S. Us imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 2008, 246, 508–518. [CrossRef] [PubMed]
67. McDonald, D.M.; Choyke, P.L. Imaging of angiogenesis: From microscope to clinic. Nat. Med. 2003, 9, 713–725. [CrossRef] [PubMed]
68. Li, W.L.; Fraser, J.L.; Yu, S.P.; Zhu, J.; Jiang, Y.J.; Wei, L. The role of VEGF/VEGFR2 signaling in peripheral stimulation-induced cerebral neurovascular regeneration after ischemic stroke in mice. Exp. Brain Res. 2011, 214, 503–513. [CrossRef] [PubMed]
69. Wu, X.D.; Wang, C.; Zhang, Z.Y.; Fu, Y.; Liu, F.Y.; Liu, X.H. Puerarin attenuates cerebral damage by improving cerebral microcirculation in spontaneously hypertensive rats. Evid.-Based Complement. Altern. Med. 2014, 2014, 408501. [CrossRef] [PubMed]
70. Gong, X.; Sucher, N.J. Stroke therapy in traditional chinese medicine (TCM): Prospects for drug discovery and development. Trends Pharmacol. Sci. 1999, 20, 191–196. [CrossRef]
71. Dohadwala, M.M.; Vita, J.A. Grapes and cardiovascular disease. J. Nutr. 2009, 139, 1788S–1793S. [CrossRef] [PubMed]
72. Shukla, S.K.; Gupta, S.; Ojha, S.K.; Sharma, S.B. Cardiovascular friendly natural products: A promising approach in the management of cvd. Nat. Prod. Res. 2010, 24, 873–898. [CrossRef] [PubMed]
73. Guo, B.C.; Wei, J.; Su, K.H.; Chiang, A.N.; Zhao, J.F.; Chen, H.Y.; Shyue, S.K.; Lee, T.S. Transient receptor potential vanilloid type 1 is vital for (_)-epigallocatechin-3-gallate mediated activation of endothelial nitric oxide synthase. Mol. Nutr. Food Res. 2015, 59, 646–657. [CrossRef] [PubMed]
74. Nada, S.E.; Tulsulkar, J.; Shah, Z.A. Heme oxygenase 1-mediated neurogenesis is enhanced by Ginkgo biloba (egb 761(r)) after permanent ischemic stroke in mice. Mol. Neurobiol. 2014, 49, 945–956. [CrossRef] [PubMed]
75. Liu, H.J.; Wang, X.L.; Zhang, L.; Qiu, Y.; Li, T.J.; Li, R.; Wu, M.C.; Wei, L.X.; Rui, Y.C. Inhibitions of vascular endothelial growth factor expression and foam cell formation by EGb 761, a special extract of ginkgo biloba, in oxidatively modified low-density lipoprotein-induced human THP-1 monocytes cells. Phytomedicine 2009, 16, 138–145. [CrossRef] [PubMed]
76. Qiu, Q.H.; Xie, Z.G.; Xu, X.; Liang, S.X.; Gao, Y. EGb 761 on retinal light injury in rats. Chin. Med. J. (Engl.) 2012, 125, 2306–2309. [PubMed]
77. Penumathsa, S.V.; Thirunavukkarasu, M.; Zhan, L.; Maulik, G.; Menon, V.P.; Bagchi, D.; Maulik, N. Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. J. Cell. Mol. Med. 2008, 12, 2350–2361. [CrossRef] [PubMed]
78. Potente, M.; Ghaeni, L.; Baldessari, D.; Mostoslavsky, R.; Rossig, L.; Dequiedt, F.; Haendeler, J.; Mione, M.; Dejana, E.; Alt, F.W.; et al. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev. 2007, 21, 2644–2658. [CrossRef] [PubMed]
79. Robich, M.P.; Chu, L.M.; Chaudray, M.; Nezafat, R.; Han, Y.; Clements, R.T.; Laham, R.J.; Manning, W.J.; Coady, M.A.; Sellke, F.W. Anti-angiogenic effect of high-dose resveratrol in a swine model of metabolic syndrome. Surgery 2010, 148, 453–462. [CrossRef] [PubMed]
80. Chan, L.S.; Yue, P.Y.; Wong, Y.Y.; Wong, R.N. MicroRNA-15b contributes to ginsenoside-Rg1-induced angiogenesis through increased expression of VEGFR-2. Biochem. Pharmacol. 2013, 86, 392–400. [CrossRef] [PubMed]
81. Leung, K.W.; Ng, H.M.; Tang, M.K.; Wong, C.C.; Wong, R.N.; Wong, A.S. Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1α to promote angiogenesis. Angiogenesis 2011, 14, 515–522. [CrossRef] [PubMed]
82. Sengupta, S.; Toh, S.A.; Sellers, L.A.; Skepper, J.N.; Koolwijk, P.; Leung, H.W.; Yeung, H.W.; Wong, R.N.; Sasisekharan, R.; Fan, T.P. Modulating angiogenesis: The Yin and the Yang in ginseng. Circulation 2004, 110, 1219–1225. [CrossRef] [PubMed]
83. Joo, S.S.; Won, T.J.; Lee, D.I. Reciprocal activity of ginsenosides in the production of proinflammatory repertoire, and their potential roles in neuroprotection in vivo. Planta Med. 2005, 71, 476–481. [CrossRef] [PubMed]
84. Zhang, Y.; Hu, G.; Li, S.; Li, Z.H.; Lam, C.O.; Hong, S.J.; Kwan, Y.W.; Chan, S.W.; Leung, G.P.; Lee, S.M. Pro-angiogenic activity of astragaloside iv in huvecs in vitro and zebrafish in vivo. Mol. Med. Rep. 2012, 5, 805–811. [PubMed]
85. Hu, G.; Mahady, G.B.; Li, S.; Hoi, M.P.; Wang, Y.H.; Lee, S.M. Polysaccharides from Astragali radix restore chemical-induced blood vessel loss in zebrafish. Vasc. Cell 2012, 4, 2. [CrossRef] [PubMed]
86. Yao, R.Q.; Zhang, L.; Wang, W.; Li, L. Cornel iridoid glycoside promotes neurogenesis and angiogenesis and improves neurological function after focal cerebral ischemia in rats. Brain Res. Bull. 2009, 79, 69–76. [CrossRef] [PubMed]
87. Tang, J.Y.; Li, S.; Li, Z.H.; Zhang, Z.J.; Hu, G.; Cheang, L.C.; Alex, D.; Hoi, M.P.; Kwan, Y.W.; Chan, S.W.; et al. Calycosin promotes angiogenesis involving estrogen receptor and mitogen-activated protein kinase (MAPK) signaling pathway in zebrafish and huvec. PLoS ONE 2010, 5, e11822. [CrossRef] [PubMed]
88. Simao, F.; Pagnussat, A.S.; Seo, J.H.; Navaratna, D.; Leung, W.; Lok, J.; Guo, S.; Waeber, C.; Salbego, C.G.; Lo, E.H. Pro-angiogenic effects of resveratrol in brain endothelial cells: Nitric oxide-mediated regulation of vascular endothelial growth factor and metalloproteinases. J. Cereb. Blood Flow Metab. 2012, 32, 884–895. [CrossRef] [PubMed]
89. Babaei, S.; Teichert-Kuliszewska, K.; Zhang, Q.; Jones, N.; Dumont, D.J.; Stewart, D.J. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am. J. Pathol. 2003, 162, 1927–1936. [CrossRef]
90. Hashiguchi, A.; Yano, S.; Morioka, M.; Hamada, J.; Ushio, Y.; Takeuchi, Y.; Fukunaga, K. Up-regulation of endothelial nitric oxide synthase via phosphatidylinositol 3-kinase pathway contributes to ischemic tolerance in the CA1 subfield of gerbil hippocampus. J. Cereb. Blood Flow Metab. 2004, 24, 271–279. [CrossRef] [PubMed]
91. Nakashima, M.N.; Ajiki, K.; Nakashima, K.; Takahashi, M. Possible role of nitric oxide in anxiety following transient cerebral ischemia in mice. J. Pharmacol. Sci. 2003, 91, 47–52. [CrossRef] [PubMed]
92. Chan, L.S.; Yue, P.Y.; Mak, N.K.; Wong, R.N. Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis. Eur. J. Pharm. Sci. 2009, 38, 370–377. [CrossRef] [PubMed]
93. Shweiki, D.; Itin, A.; Soffer, D.; Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359, 843–845. [CrossRef] [PubMed]
94. Ai, F.; Chen, M.; Li, W.; Yang, Y.; Xu, G.; Gui, F.; Liu, Z.; Bai, X.; Chen, Z. Danshen improves damaged cardiac angiogenesis and cardiac function induced by myocardial infarction by modulating Hif1α/VEGFA signaling pathway. Int. J. Clin. Exp. Med. 2015, 8, 18311–18318. [PubMed]
95. Tang, B.; Qu, Y.; Wang, D.; Mu, D. Targeting hypoxia inducible factor-1α: A novel mechanism of ginsenoside Rg1 for brain repair after hypoxia/ischemia brain damage. CNS Neurol. Disord. Drug Targets 2011, 10, 235–238. [CrossRef] [PubMed]
96. Zhang, Q.; Zhao, Y.H. Therapeutic angiogenesis after ischemic stroke: Chinese medicines, bone marrow stromal cells (BMSCS) and their combinational treatment. Am. J. Chin. Med. 2014, 42, 61–77. [CrossRef] [PubMed]
97. Bang, O.Y.; Lee, J.S.; Lee, P.H.; Lee, G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 2005, 57, 874–882. [CrossRef] [PubMed]
98. Hu, X.Y.; Wang, W.X.; Yu, M.J.; Liu, X.B.; Wu, R.R.; Gao, F.; Huang, X.; Cao, J.; Xie, X.J.; Wang, J.A. Tongxinluo promotes mesenchymal stem cell tube formation in vitro. J. Zhejiang Univ. Sci. B 2011, 12, 644–651. [CrossRef] [PubMed]
99. Wu, T.; Harrison, R.A.; Chen, X.; Ni, J.; Zhou, L.; Qiao, J.; Wang, Q.; Wei, J.; Xin, D.; Zheng, J. Tongxinluo (tong xin luo or tong-xin-luo) capsule for unstable angina pectoris. Cochrane Database Syst. Rev. 2006, CD004474.
100. Li, X.D.; Yang, Y.J.; Geng, Y.J.; Jin, C.; Hu, F.H.; Zhao, J.L.; Zhang, H.T.; Cheng, Y.T.; Qian, H.Y.; Wang, L.L.; et al. Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of enos via the PKA pathway. Am. J. Physiol. Heart Circ. Physiol. 2010, 299, H1255–H1261. [CrossRef] [PubMed]
101. Yu, Z.H.; Cai, M.; Xiang, J.; Zhang, Z.N.; Zhang, J.S.; Song, X.L.; Zhang, W.; Bao, J.; Li, W.W.; Cai, D.F. PI3K/Akt pathway contributes to neuroprotective effect of tongxinluo against focal cerebral ischemia and reperfusion injury in rats. J. Ethnopharmacol. 2016, 181, 8–19. [CrossRef] [PubMed]
102. Chang, L.P.; Wei, C.; Jia, Z.H. Effects of tongxinluo on angiogenesis and the volume of blood perfusion in ischemic stroke rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2012, 32, 1667–1670. [PubMed]
103. Chen, L.; Wang, X.; Chen, X.; Xing, S.; Zhang, J.; Li, J.; Dang, C.; Liu, G.; Dang, G.; Zeng, J. Tongxinluo attenuates neuronal loss and enhances neurogenesis and angiogenesis in the ipsilateral thalamus and improves neurological outcome after focal cortical infarction in hypertensive rats. Restor. Neurol. Neurosci. 2014, 32, 533–546. [PubMed]
104. Chen, L.; Wang, X.; Zhang, J.; Dang, C.; Liu, G.; Liang, Z.; Huang, G.; Zhao, W.; Zeng, J. Tongxinluo enhances neurogenesis and angiogenesis in peri-infarct area and subventricular zone and promotes functional recovery after focal cerebral ischemic infarction in hypertensive rats. Evid.-Based Complement. Altern. Med. 2016, 2016, 8549590. [CrossRef] [PubMed]
105. Li, Z.; Wang, H.; Wang, Q.; Sun, J. Buyang huanwu decoction vigorously rescues PC12 cells against 6-OHDA-induced neurotoxicity via Akt/GSK3β pathway based on serum pharmacology methodology. Rejuvenation Res. 2016. [CrossRef] [PubMed]
106. Dong, X.-H.; He, X.-P.; Gao, W.-J. Neuroprotective effects of the buyang huanwu decoction on functional recovery in rats following spinal cord injury. J. Spinal Cord Med. 2016, 39, 85–92.
107. Cai, G.X.; Liu, B.Y. Effect of ultra-micronized buyang huanwu decoction on neurological function, quality of life, and serum vascular endothelial growth factor in patients convalescent from cerebral infarction. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2010, 22, 591–594. [PubMed]
108. Yang, J.; Gao, F.; Zhang, Y.; Liu, Y.; Zhang, D. Buyang huanwu decoction (BYHWD) enhances angiogenic effect of mesenchymal stem cell by upregulating vegf expression after focal cerebral ischemia. J. Mol. Neurosci. 2015, 56, 898–906. [CrossRef] [PubMed]
109. Cui, H.J.; Yang, A.L.; Zhou, H.J.; Wang, C.; Luo, J.K.; Lin, Y.; Zong, Y.X.; Tang, T. Buyang huanwu decoction promotes angiogenesis via vascular endothelial growth factor receptor-2 activation through the PI3K/Akt pathway in a mouse model of intracerebral hemorrhage. BMC Complement. Altern. Med. 2015, 15, 91. [CrossRef] [PubMed]
110. Chung, M.H.; Suzuki, S.; Nishihara, T.; Hattori, M. Estrogenic effects of a kampo formula, tokishakuyakusan, in parous ovariectomized rats. Biol. Pharm. Bull. 2008, 31, 1145–1149. [CrossRef] [PubMed]
111. Lin, Z.; Zhu, D.; Yan, Y.; Yu, B. Herbal formula FBD extracts prevented brain injury and inflammation induced by cerebral ischemia-reperfusion. J. Ethnopharmacol. 2008, 118, 140–147. [CrossRef] [PubMed]
112. Hatip-Al-Khatib, I.; Hatip, F.B.; Yoshimitsu, Y.; Iwasaki, K.; Egashira, N.; Liu, A.X.; Mishima, K.; Fujiwara, M. Effect of toki-shakuyaku-san on acetylcholine level and blood flow in dorsal hippocampus of intact and twice-repeated ischemic rats. Phytother. Res. 2007, 21, 291–294. [CrossRef] [PubMed]
113. Ren, C.; Wang, B.; Li, N.; Jin, K.; Ji, X. Herbal formula danggui-shaoyao-san promotes neurogenesis and angiogenesis in rat following middle cerebral artery occlusion. Aging Dis. 2015, 6, 245–253. [CrossRef] [PubMed]
114. Lan, Z.; Liu, J.; Chen, L.; Fu, Q.; Luo, J.; Qu, R.; Kong, L.; Ma, S. Danggui-shaoyao-san ameliorates cognition deficits and attenuates oxidative stress-related neuronal apoptosis in D-galactose-induced senescent mice. J. Ethnopharmacol. 2012, 141, 386–395. [CrossRef] [PubMed]
115. Wang, J.; Yuan, Z.; Zhao, H.; Ju, D.; Chen, Y.; Chen, X.; Zhang, J. Ferulic acid promotes endothelial cells proliferation through up-regulating cyclin D1 and VEGF. J. Ethnopharmacol. 2011, 137, 992–997. [CrossRef] [PubMed]
116. Zhu, Z.; Zhou, X.; He, B.; Dai, T.; Zheng, C.; Yang, C.; Zhu, S.; Zhu, J.; Zhu, Q.; Liu, X. Ginkgo biloba extract (EGb 761) promotes peripheral nerve regeneration and neovascularization after acellular nerve allografts in a rat model. Cell. Mol. Neurobiol. 2015, 35, 273–282. [CrossRef] [PubMed]
117. Kwok, H.H.; Chan, L.S.; Poon, P.Y.; Yue, P.Y.; Wong, R.N. Ginsenoside-Rg1 induces angiogenesis by the inverse regulation of met tyrosine kinase receptor expression through miR-23a. Toxicol. Appl. Pharmacol. 2015, 287, 276–283. [CrossRef] [PubMed]
118. Wang, X.D.; Gu, T.X.; Shi, E.Y.; Lu, C.M.; Wang, C. Effect and mechanism of panaxoside Rg1 on neovascularization in myocardial infarction rats. Chin. J. Integr. Med. 2010, 16, 162–166. [CrossRef] [PubMed]
119. Shen, K.; Ji, L.; Gong, C.; Ma, Y.; Yang, L.; Fan, Y.; Hou, M.; Wang, Z. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated vegf secretion and the regulation of PI3K/Akt and Raf/MEK/ERK signaling pathways. Biochem. Pharmacol. 2012, 84, 784–792. [CrossRef] [PubMed]
120. Wang, S.G.; Xu, Y.; Chen, J.D.; Yang, C.H.; Chen, X.H. Astragaloside IV stimulates angiogenesis and increases nitric oxide accumulation via JAK2/STAT3 and ERK1/2 pathway. Molecules 2013, 18, 12809–12819. [CrossRef] [PubMed]
121. Liu, C.L.; Kwok, H.F.; Cheng, L.; Ko, C.H.; Wong, C.W.; Ho, T.W.; Leung, P.C.; Fung, K.P.; Lau, C.B. Molecular mechanisms of angiogenesis effect of active sub-fraction from root of Rehmannia glutinosa by zebrafish sprout angiogenesis-guided fractionation. J. Ethnopharmacol. 2014, 151, 565–575. [CrossRef] [PubMed]
122. Li, Y.J.; Duan, C.L.; Liu, J.X. Salvianolic acid a promotes the acceleration of neovascularization in the ischemic rat myocardium and the functions of endothelial progenitor cells. J. Ethnopharmacol. 2014, 151, 218–227. [CrossRef] [PubMed]
123. Zhang, Z.R.; Li, J.H.; Li, S.; Liu, A.L.; Hoi, P.M.; Tian, H.Y.; Ye, W.C.; Lee, S.M.; Jiang, R.W. In vivo angiogenesis screening and mechanism of action of novel tanshinone derivatives produced by one-pot combinatorial modification of natural tanshinone mixture from Salvia miltiorrhiza. PLoS ONE 2014, 9, e100416. [CrossRef] [PubMed]
124. Shen, J.; Zhu, Y.; Yu, H.; Fan, Z.X.; Xiao, F.; Wu, P.; Zhang, Q.H.; Xiong, X.X.; Pan, J.W.; Zhan, R.Y. Buyang huanwu decoction increases angiopoietin-1 expression and promotes angiogenesis and functional outcome after focal cerebral ischemia. J. Zhejiang Univ. Sci. B 2014, 15, 272–280. [CrossRef] [PubMed]
125. Wang, J.; Zhou, J.; Ding, X.; Zhu, L.; Jiang, K.; Fu, M.; Wang, S.; Hu, K.; Ge, J. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction. Int. J. Clin. Exp. Pathol. 2015, 8, 6596–6606. [PubMed]
126. Lin, J.M.; Zhao, J.Y.; Zhuang, Q.C.; Hong, Z.F.; Peng, J. Xiongshao capsule promotes angiogenesis of huvec via enhancing cell proliferation and up-regulating the expression of BFGF and VEGF. Chin. J. Integr. Med. 2011, 17, 840–846. [CrossRef] [PubMed]
127. Lin, F.; Chen, B.L.; Wang, Y.Z.; Gao, D.; Song, J.; Kaptchuk, T.J.; Chen, K.J. In vitro angiogenesis effect of xuefu zhuyu decoction () and vascular endothelial growth factor: A comparison study. Chin. J. Integr. Med. 2015. [CrossRef] [PubMed]
128. Wang, Z.T.; Zhang, S.J.; Han, L.H.; Chai, S.B. Effects of xuesetong soft capsules on angiogenesis and VEGF mRNA expression in ischemic myocardium in rats with myocardial infarction. J. Tradit. Chin. Med. 2012, 32, 71–74. [CrossRef]